156
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre

ORCID Icon, , , , , , , & show all
Pages 2037-2048 | Received 22 Aug 2023, Accepted 03 Nov 2023, Published online: 08 Nov 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.